BioSpace News Archive

Business

Stratasys Teams with Dassault Systèmes and Industry Visionary Easton LaChappelle for Major 3D Printing, Prosthetics Initiative

Stratasys announced the company is teaming with Dassault Systèmes and industry innovator Easton LaChappelle to power a transformational new initiative - Unlimited Tomorrow.

February 5, 2018

·

7 min read

BioAmber Announces Underwritten Offering

The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

February 5, 2018

·

4 min read

Business

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on February 26, 2018

The Company will host a conference call the following morning, Tuesday, February 27, 2018, at 9:00 a.m. ET to discuss these results.

February 5, 2018

·

1 min read

Policy

EnzymeWorks, Inc. and Codexis, Inc. Reach a Settlement Agreement

All claims against EnzymeWorks’ founder Alex Tao have been dismissed with prejudice.

February 5, 2018

·

2 min read

Business

BIO’s Statement on the Confirmation of Andrei Iancu to Lead the U.S. Patent and Trademark Office

The following statement may be attributed to BIO President & CEO James Greenwood: “I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (PTO).”

February 5, 2018

·

1 min read

Drug Development

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

The FDA has granted Orphan Drug Designation to FCX-013 for the treatment of localized scleroderma.

February 5, 2018

·

6 min read

Policy

AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme (ferumoxytol injection)

This sNDA approval immediately doubles the number of patients who could benefit from Feraheme to include both CKD and non-CKD patients.

February 5, 2018

·

6 min read

Intellegens Secures First Commercial Contract for Alchemite Technology

The potential of Intellegens’ Alchemite AI technology has been demonstrated with the recent announcement of a commercial collaboration between the Cambridge-based company and e-Therapeutics.

February 5, 2018

·

2 min read

Genetown

Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5 in a Topical Application

The authors report that in this single-blind study, wounds were randomized to receive AC5 or control treatment after sequential shave excision of two lesions in the same patient

February 5, 2018

·

6 min read

Biotech Beach

Human Longevity Release: New Metabolomic and Genomic-Informed Study Shows Use of Acetaminophen Has Unexpected Effects on Regulation of Sex Hormones

The study, published in the journal EBioMedicine, highlights the power of genomic and metabolomic profiling to better understand drug mechanisms of action and metabolism even in common drugs such as acetaminophen.

February 5, 2018

·

3 min read